Bacterial pneumonia epidemiology and demographics

Revision as of 14:29, 27 January 2022 by Jose Loyola (talk | contribs)
Jump to navigation Jump to search

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Arooj Naz

Pneumonia Main Page

Bacterial pneumonia Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Bacterial pneumonia from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Bacterial pneumonia epidemiology and demographics On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Bacterial pneumonia epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Bacterial pneumonia epidemiology and demographics

CDC onBacterial pneumonia epidemiology and demographics

Bacterial pneumonia epidemiology and demographics in the news

Blogs on Bacterial pneumonia epidemiology and demographics

to Hospitals Treating Bacterial pneumonia

Risk calculators and risk factors for Bacterial pneumonia epidemiology and demographics

Overview

  • Pneumonia is a condition seen in the vast majority of regions, but pneumonia related deaths have been disproportionally higher in low and middle income nations, including the sub-Saharan African and South Asian regions.[1]
  • Pneumonia case rates are primarily affected by factors relating to seasonal variations. Studies show that a majority of Streptococcus pneumoniae cases were most prevalent during the winter, whereas far fewer cases presented in the summertime in comparison.[2] Specifications regarding geography are of considerable importance in regards to fungal pneumonia.[3]

Incidence

  • Approximately 5 million people are affected every year in the United States alone, with outpatients making up the majority at 80% but having a low mortality rate of 1%. Up to half of the patients that are admitted into hospitals succumb to the disease.[4]
  • Worldwide, the incidence of community acquired pneumonia averages 1.5-14 cases per every 1000 individuals.[3]
  • The incidence in the United States is approximately 25 cases per 10,000 adults.[3]
  • The CDC estimates that Streptococcus pneumoniae alone is responsible for nearly 150,000 hospitalizations in the United States annually.[5]

References

  1. Roomaney RA, Pillay-van Wyk V, Awotiwon OF, Dhansay A, Groenewald P, Joubert JD; et al. (2016). "Epidemiology of lower respiratory infection and pneumonia in South Africa (1997-2015): a systematic review protocol". BMJ Open. 6 (9): e012154. doi:10.1136/bmjopen-2016-012154. PMC 5030548. PMID 27633638.
  2. Herrera-Lara S, Fernández-Fabrellas E, Cervera-Juan Á, Blanquer-Olivas R (2013). "Do seasonal changes and climate influence the etiology of community acquired pneumonia?". Arch Bronconeumol. 49 (4): 140–5. doi:10.1016/j.arbres.2012.11.001. PMID 23305778.
  3. 3.0 3.1 3.2 "StatPearls". 2021. PMID 28613500.
  4. "StatPearls". 2021. PMID 30020693.
  5. "CDC Pneumococcal Disease Clinical Features".

Template:WH Template:WS